Efficacy and safety of imeglimin in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized clinical trials.

Background And Aim: Imeglimin is a novel tetrahydrotriazine-containing drug suggested as a safe drug for glycemic management in patients with type 2 diabetes mellitus (T2DM). We aimed to 1) evaluate the efficacy of imeglimin on glycemic control and insulin resistance improvement measured by homeostatic model assessment of insulin resistance (HOMA-IR). 2) assess whether the novel drug improves lipid parameters in diabetic patients.

Microtensile Bond Strength, Marginal Leakage, and Antibacterial Effect of Bulk Fill Resin Composite with Alkaline Fillers versus Incremental Nanohybrid Composite Resin.

Objective:  This study aimed to investigate the microtensile bond strength (µTBS), microleakage, and antibacterial effect of bulk fill resin composite with alkaline fillers (alkasite) (alkaline fillers such as barium aluminum silicate glass and ytterbium trifluoride) in comparison to incremental nanohybrid resin composite.

Materials And Methods:  µTBS was evaluated by using 30 human mandibular molars. Teeth were randomly divided into three groups (C): nanohybrid resin composite (C0), self-cured alkasite (C1), and dual-cured alkasite (C2).